Derivative chromosome 9 deletions in chronic myeloid leukaemia: interpretation of atypical D-FISH pattern

被引:12
作者
Wan, TSK
Ma, SK
Au, WY
Chan, LC
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Div Haematol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1136/jcp.56.6.471
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background/Aims: New molecular cytogenetic techniques are increasingly applied as a routine investigative tool in haematological malignancies, both at diagnosis and subsequent monitoring. This report describes the interpretation of atypical signal patterns encountered using BCR - ABL dual colour dual fusion fluorescence in situ hybridisation (D-FISH) translocation probes in chronic myeloid leukaemia (CML). Methods: Interphase FISH experiments were carried out using BCR - ABL D-FISH probes in 46 patients with CML at diagnosis and during subsequent disease monitoring. Atypical hybridisation signal patterns were characterised by molecular cytogenetic techniques and correlated with conventional karyotyping. Results: Two patients showed atypical interphase D-FISH patterns with one orange, one green, and one fusion (1O1G1F) signal. The presence of BCR - ABL gene fusion was documented by a dual colour single fusion (S-FISH) probe. The submicroscopic deletion of the ABL - BCR fusion gene on the derivative chromosome 9 in these cases was subsequently characterised by metaphase FISH on relocated G banded metaphases. Conclusions: Atypical interphase D-FISH patterns should not be interpreted in isolation and should be considered in conjunction with other cytogenetic or molecular genetic investigations.
引用
收藏
页码:471 / 474
页数:4
相关论文
共 10 条
[1]   A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia [J].
Buño, I ;
Wyatt, WA ;
Zinsmeister, AR ;
Dietz-Band, J ;
Silver, RT ;
Dewald, GW .
BLOOD, 1998, 92 (07) :2315-2321
[2]   A multicenter investigation with D-FISH BCR/ABL1 probes [J].
Dewald, G ;
Stallard, R ;
Alsaadi, A ;
Arnold, S ;
Blough, R ;
Ceperich, TM ;
Elejalde, BR ;
Fink, J ;
Higgins, JV ;
Higgins, RR ;
Hoeltge, GA ;
Hsu, WT ;
Johnson, EB ;
Kronberger, D ;
McCorquodale, DJ ;
Meisner, LF ;
Micale, MA ;
Oseth, L ;
Payne, JS ;
Schwartz, S ;
Sheldon, S ;
Sophian, A ;
Storto, P ;
Van Tuinen, P ;
Wenger, GD ;
Wiktor, A ;
Willis, LA ;
Yung, JF ;
Zenger-Hain, J .
CANCER GENETICS AND CYTOGENETICS, 2000, 116 (02) :97-104
[3]   THE APPLICATION OF FLUORESCENT IN-SITU HYBRIDIZATION TO DETECT MBCR/ABL FUSION IN VARIANT PH CHROMOSOMES IN CML AND ALL [J].
DEWALD, GW ;
SCHAD, CR ;
CHRISTENSEN, ER ;
TIEDE, AL ;
ZINSMEISTER, AR ;
SPURBECK, JL ;
THIBODEAU, SN ;
JALAL, SM .
CANCER GENETICS AND CYTOGENETICS, 1993, 71 (01) :7-14
[4]   Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia [J].
Dewald, GW ;
Wyatt, WA ;
Juneau, AL ;
Carlson, RO ;
Zinsmeister, AR ;
Jalal, SM ;
Spurbeck, JL ;
Silver, RT .
BLOOD, 1998, 91 (09) :3357-3365
[5]   FISH analysis for CML monitoring? [J].
Froncillo, MCC ;
Maffei, L ;
Cantonetti, M ;
DelPoeta, G ;
Lentini, R ;
Bruno, A ;
Masi, M ;
Tribalto, M ;
Amadori, S .
ANNALS OF HEMATOLOGY, 1996, 73 (03) :113-119
[6]  
Grand F, 1999, CANCER RES, V59, P3870
[7]   Derivative chromosome 9 deletions in chronic myeloid leukemia:: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability [J].
Huntly, BJP ;
Bench, AJ ;
Delabesse, E ;
Reid, AG ;
Li, J ;
Scott, MA ;
Campbell, L ;
Byrne, J ;
Pinto, E ;
Brizard, A ;
Niedermeiser, D ;
Nacheva, EP ;
Guilhot, F ;
Deininger, M ;
Green, AR .
BLOOD, 2002, 99 (12) :4547-4553
[8]   Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia [J].
Huntly, BJP ;
Reid, AG ;
Bench, AJ ;
Campbell, LJ ;
Telford, N ;
Shepherd, P ;
Szer, J ;
Prince, HM ;
Turner, P ;
Grace, C ;
Nacheva, EP ;
Green, AR .
BLOOD, 2001, 98 (06) :1732-1738
[9]   Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia [J].
Sinclair, PB ;
Nacheva, EP ;
Leversha, M ;
Telford, N ;
Chang, J ;
Reid, A ;
Bench, A ;
Champion, K ;
Huntly, B ;
Green, AR .
BLOOD, 2000, 95 (03) :738-744
[10]   Cytogenetic biclonality in polycythemia vera: unusual and unrelated clones [J].
Wan, TSK ;
Ma, SK ;
Ho, MY ;
Chan, LC ;
Yip, SF ;
Wong, LG ;
Yeung, YM .
CANCER GENETICS AND CYTOGENETICS, 2001, 131 (01) :86-89